What's in Gynaecologisch Oncologisch Centrum Zuid's pipeline?

Gynaecologisch Oncologisch Centrum Zuid has 3 drugs in our index: 0 marketed, 0 filed, 0 in Phase 3, 3 in Phase 2, 0 in Phase 1.

Which companies overlap with Gynaecologisch Oncologisch Centrum Zuid's portfolio?

Top competitors by shared drug class: AstraZeneca, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh, Dharmais National Cancer Center Hospital, Eastern Virginia Medical School, Genor Biopharma Co., Ltd..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/gynaecologisch-oncologisch-centrum-zuid.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Gynaecologisch Oncologisch Centrum Zuid — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Gynaecologisch Oncologisch Centrum Zuid pipeline: 0 marketed, 0 filed, 0 Phase 3, 3 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 0 Phase 3 3 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

No leading-phase drugs tracked for this sponsor.

Therapeutic area mix

Oncology · 2

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

AstraZeneca · 1 shared drug class
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh · 1 shared drug class
Dharmais National Cancer Center Hospital · 1 shared drug class
Eastern Virginia Medical School · 1 shared drug class
Genor Biopharma Co., Ltd. · 1 shared drug class
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy · 1 shared drug class
IVI Madrid · 1 shared drug class
Amgen · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Gynaecologisch Oncologisch Centrum Zuid:

Cite this brief

Drug Landscape (2026). Gynaecologisch Oncologisch Centrum Zuid — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/gynaecologisch-oncologisch-centrum-zuid. Accessed 2026-05-17.